(PowerPoint)
New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong.
Lung
Genomica en cancer de pulmon.final.1
Second line therapy for nsclc
Questions and answers about PARAMOUNT: phase III study of pemetrexed continuation maintenance therapy in advanced non-squamous NSCLC.
Simon K. Cheng 1, Kevin Stephenson 2, Lynn Shi 2, Kunal Chaudhary 1, Anshu Jain 1, David P. Horowitz 1, Sherry X. Yan 2, Tony Wang 1, Clifford Chao 1,
Hovav Nechushtan Hadassah Hebrew University Medical center.
Seeing Beyond Age in the Management of Advanced Lung Cancer
Giorgio Mustacchi NSCLC: Targeting angiogenesis. NON-SMALL CELL LUNG CANCER.
Azienda ULSS 13 – Mirano VE Dipartimento di Scienze Mediche U.O.C. di Oncologia & Ematologia Oncologica Ufficio di Epidemiologia & Sperimentazioni Cliniche.
A paradigm shift in the treatment of advanced lung cancer: survival and symptom benefits with Tarceva Tudor-Eliade Ciuleanu Cancer Institute Ion Chiricuta.
